RANI Kate Mckinley buys $30K worth of shares
Dec 17, 2024, 8:33 AM
-5.42%
What does RANI do
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company based in San Jose, California, focuses on developing oral delivery technologies like the RaniPill capsule for biologics and drugs. The company went public on July 30, 2021, and has a pipeline that includes multiple drug candidates.
Kate Mckinley bought 17,960 shares of RANI on 13 December at $1.67 per share, worth a total of $30K. They now own 17,960 RANI shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
